Dedifferentiated liposarcoma Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Mar 2026Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

National Cancer Institute (NCI) — PHASE1, PHASE2

TrialRECRUITING

Mar 2025Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Lamassu Bio Inc — PHASE1, PHASE2

TrialRECRUITING

Dec 2024First-line Treatment of Advanced/unresectable DDLPS

Fudan University — PHASE2

TrialNOT YET RECRUITING

Sep 2024Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

National Cancer Institute (NCI) — PHASE3

TrialRECRUITING

Jun 2024A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)

Lund University Hospital — PHASE2

TrialRECRUITING

Feb 2024Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING

Jun 2023Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Alliance for Clinical Trials in Oncology — PHASE2

TrialACTIVE NOT RECRUITING

May 2023A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Memorial Sloan Kettering Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING

Nov 2022A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Memorial Sloan Kettering Cancer Center — PHASE1

TrialRECRUITING

Nov 2021SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Sarcoma Alliance for Research through Collaboration — PHASE3

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Dedifferentiated liposarcoma.
Check the disease page for updates →

Clinical Trial Landscape

11 active trials

2Phase 3

5Phase 2

3Phase 1

1PHASE1, PHASE2

11Total recruiting

Search clinical trials for Dedifferentiated liposarcoma →

Recent News & Research

No recent news articles indexed yet for Dedifferentiated liposarcoma.
Search PubMed for Dedifferentiated liposarcoma →

Browse all Dedifferentiated liposarcoma news →

Specialist Network

Top 6 by expertise

Neeta Somaiah, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 343 trials

Christina L Roland

M.D. Anderson Cancer Center

📍 WESTAMPTON, NJ

Score 322 trials2 pubs

Antoine Italiano, M.D

Institut Bergonie Cancer Center

📍 Bordeaux, NY

Score 256 trials

Sandra P D'Angelo, PhD

Alliance for Clinical Trials in Oncology

📍 SPRINGFIELD, MO

Score 241 trial

Mark Dickson, MD

Memorial Sloan Kettering Cancer Center

Score 223 trials

Seth M Pollack, MD

ECOG-ACRIN Cancer Research Group

📍 CHICAGO, IL

Score 221 trial

View all Dedifferentiated liposarcoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰